Advances in identification of clinical yeast isolates by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry

Journal of Clinical Microbiology

Volumn 51, Issue 5, 2013, Pages 1359-1366

  Buchan, Blake W ^a,b   Ledeboer, Nathan A ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b DYNACARE LABORATORIES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ECHINOCANDIN; FLUCONAZOLE; PEPTIDE NUCLEIC ACID; PYRROLE DERIVATIVE;

ANTIBIOTIC SENSITIVITY; BLOOD CULTURE; BROTH DILUTION; CANDIDA; CENTRIFUGATION; CONCENTRATION RESPONSE; CRYPTOCOCCUS NEOFORMANS; CULTURE MEDIUM; EXTRACTION; FLUORESCENCE IN SITU HYBRIDIZATION; FUNGAL STRAIN; FUNGUS CULTURE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; GEOTRICHUM; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ON PLATE EXTRACTION; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; TRICHOSPORON; TUBE BASED EXTRACTION; CANDIDIASIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS; DEVICES; DRUG EFFECTS; HUMAN; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGICAL EXAMINATION; PROCEDURES; YEAST;

BACTERIA (MICROORGANISMS);

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOLOGICAL TYPING TECHNIQUES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; YEASTS;

EID: 84876705043     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03105-12     Document Type: Review

References (51)

1. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317.
2. McNeil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA, Plikaytis BD, Warnock DW. 2001. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin. Infect. Dis. 33:641-647.
3. Pfaller MA, Diekema DJ. 2010. Epidemiology of invasive mycoses in North America. Crit. Rev. Microbiol. 36:1-53.
4. Lockhart SR, Iqbal N, Cleveland AA, Farley MM, Harrison LH, Bolden CB, Baughman W, Stein B, Hollick R, Park BJ, Chiller T. 2012. Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. J. Clin. Microbiol. 50:3435-3442.
5. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V, Rodloff A, Fu W, Ling TA, Global Antifungal Surveillance Group. 2010. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J. Clin. Microbiol. 48:1366-1377.
6. Pappas PG, Kauffman CA, Andes D, Benjamin DK, Jr, Calandra TF, Edwards JE, Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD, Infectious Diseases Society of America. 2009. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48:503-535.
7. Pfaller MA, Diekema DJ. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20:133-163.
8. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts; third informational supplement. CLSI document M27-S3. Clinical and Laboratory Standards Institute, Wayne, PA.
9. Pfaller MA, Diekema DJ. 2012. Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012. J. Clin. Microbiol. 50:2846-2856.
10. Silva AP, Miranda IM, Lisboa C, Pina-Vaz C, Rodrigues AG. 2009. Prevalence, distribution, and antifungal susceptibility profiles of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis in a tertiary care hospital. J. Clin. Microbiol. 47:2392-2397.
11. Chitasombat MN, Kofteridis DP, Jiang Y, Tarrand J, Lewis RE, Kontoyiannis DP. 2012. Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer. J. Infect. 64:68-75.
12. Cherkaoui A, Hibbs J, Emonet S, Tangomo M, Girard M, Francois P, Schrenzel J. 2010. Comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry methods with conventional phenotypic identification for routine identification of bacteria to the species level. J. Clin. Microbiol. 48:1169-1175.
13. Jamal WY, Shahin M, Rotimi VO. 14 December 2012. Comparison of two matrix-assisted laser desorption ionization-time of flight (MALDITOF) mass spectrometry methods and API 20AN for identification of clinically relevant anaerobic bacteria. J. Med. Microbiol. [Epub ahead of print.] doi:10.1099/jmm.0.053256-0.
14. Marko DC, Saffert RT, Cunningham SA, Hyman J, Walsh J, Arbefeville S, Howard W, Pruessner J, Safwat N, Cockerill FR, Bossler AD, Patel R, Richter SS. 2012. Evaluation of the Bruker Biotyper and Vitek MS matrixassisted laser desorption ionization-time of flight mass spectrometry systems for identification of nonfermenting gram-negative bacilli isolated from cultures from cystic fibrosis patients. J. Clin. Microbiol. 50:2034-2039.
15. Martiny D, Busson L, Wybo I, El Haj RA, Dediste A, Vandenberg O. 2012. Comparison of the Microflex LT and Vitek MS systems for routine identification of bacteria by matrix-assisted laser desorption ionizationtime of flight mass spectrometry. J. Clin. Microbiol. 50:1313-1325.
16. Benagli C, Rossi V, Dolina M, Tonolla M, Petrini O. 2011. Matrixassisted laser desorption ionization-time of flight mass spectrometry for the identification of clinically relevant bacteria. PLoS One 6(1):e16424. doi:10.1371/journal.pone.0016424.
17. Saffert RT, Cunningham SA, Ihde SM, Jobe KE, Mandrekar J, Patel R. 2011. Comparison of Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometer to BD Phoenix automated microbiology system for identification of gram-negative bacilli. J. Clin. Microbiol. 49:887-892.
18. Tan KE, Ellis BC, Lee R, Stamper PD, Zhang SX, Carroll KC. 2012. Prospective evaluation of a matrix-assisted laser desorption ionizationtime of flight mass spectrometry system in a hospital clinical microbiology laboratory for identification of bacteria and yeasts: a bench-by-bench study for assessing the impact on time to identification and costeffectiveness. J. Clin. Microbiol. 50:3301-3308.
19. Dealler SF. 1991. Candida albicans colony identification in 5 minutes in a general microbiology laboratory. J. Clin. Microbiol. 29:1081-1082.
20. Willinger B, Wein S, Hirschl AM, Rotter ML, Manafi M. 2005. Comparison of a new commercial test, GLABRATA RTT, with a dipstick test for rapid identification of Candida glabrata. J. Clin. Microbiol. 43:499-501.
21. Ramani R, Gromadzki S, Pincus DH, Salkin IF, Chaturvedi V. 1998. Efficacy of API 20C and ID 32C systems for identification of common and rare clinical yeast isolates. J. Clin. Microbiol. 36:3396-3398.
22. Verweij PE, Breuker IM, Rijs AJ, Meis JF. 1999. Comparative study of seven commercial yeast identification systems. J. Clin. Pathol. 52:271-273.
23. Ghelardi E, Pichierri G, Castagna B, Barnini S, Tavanti A, Campa M. 2008. Efficacy of chromogenic Candida agar for isolation and presumptive identification of pathogenic yeast species. Clin. Microbiol. Infect. 14:141-147.
24. Hospenthal DR, Beckius ML, Floyd KL, Horvath LL, Murray CK. 2006. Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida. Ann. Clin. Microbiol. Antimicrob. 5:1. doi:10.1186/1476-0711-5-1.
25. Hall L, Le Febre KM, Deml SM, Wohlfiel SL, Wengenack NL. 2012. Evaluation of the Yeast Traffic LightPNAFISH probes for identification of Candida species from positive blood cultures. J. Clin. Microbiol. 50:1446-1448.
26. Shepard JR, Addison RM, Alexander BD, Della-Latta P, Gherna M, Haase G, Hall G, Johnson JK, Merz WG, Peltroche-Llacsahuanga H, Stender H, Venezia RA, Wilson D, Procop GW, Wu F, Fiandaca MJ. 2008. Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles. J. Clin. Microbiol. 46:50-55.
27. Reller ME, Mallonee AB, Kwiatkowski NP, Merz WG. 2007. Use of peptide nucleic acid-fluorescence in situ hybridization for definitive, rapid identification of five common Candida species. J. Clin. Microbiol. 45: 3802-3803.
28. van Veen SQ, Claas EC, Kuijper EJ. 2010. High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionizationtime of flight mass spectrometry in conventional medical microbiology laboratories. J. Clin. Microbiol. 48:900-907.
29. Dhiman N, Hall L, Wohlfiel SL, Buckwalter SP, Wengenack NL. 2011. Performance and cost analysis of matrix-assisted laser desorption ionization-time of flight mass spectrometry for routine identification of yeast. J. Clin. Microbiol. 49:1614-1616.
30. Goyer M, Lucchi G, Ducoroy P, Vagner O, Bonnin A, Dalle F. 2012. Optimization of the preanalytical steps of matrix-assisted laser desorption ionization-time of flight mass spectrometry identification provides a flexible and efficient tool for identification of clinical yeast isolates in medical laboratories. J. Clin. Microbiol. 50:3066-3068.
31. Bader O, Weig M, Taverne-Ghadwal L, Lugert R, Gross U, Kuhns M. 2011. Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin. Microbiol. Infect. 17:1359-1365.
32. Marklein G, Josten M, Klanke U, Muller E, Horre R, Maier T, Wenzel T, Kostrzewa M, Bierbaum G, Hoerauf A, Sahl HG. 2009. Matrixassisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J. Clin. Microbiol. 47:2912-2917.
33. Theel ES, Schmitt BH, Hall L, Cunningham SA, Walchak RC, Patel R, Wengenack NL. 2012. Formic acid-based direct, on-plate testing of yeast and Corynebacterium species by Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 50:3093-3095.
34. Van Herendael BH, Bruynseels P, Bensaid M, Boekhout T, De Baere T, Surmont I, Mertens AH. 2012. Validation of a modified algorithm for the identification of yeast isolates using matrix-assisted laser desorption/ ionisation time-of-flight mass spectrometry (MALDI-TOF MS). Eur. J. Clin. Microbiol. Infect. Dis. 31:841-848.
35. Iriart X, Lavergne RA, Fillaux J, Valentin A, Magnaval JF, Berry A, Cassaing S. 2012. Routine identification of medical fungi by the new Vitek MS matrix-assisted laser desorption ionization-time of flight system with a new time-effective strategy. J. Clin. Microbiol. 50:2107-2110.
36. Stevenson LG, Drake SK, Shea YR, Zelazny AM, Murray PR. 2010. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of clinically important yeast species. J. Clin. Microbiol. 48:3482-3486.
37. Alexander BD, Ashley ED, Reller LB, Reed SD. 2006. Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures. Diagn. Microbiol. Infect. Dis. 54:277-282.
38. Ferroni A, Suarez S, Beretti JL, Dauphin B, Bille E, Meyer J, Bougnoux ME, Alanio A, Berche P, Nassif X. 2010. Real-time identification of bacteria and Candida species in positive blood culture broths by matrixassisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 48:1542-1548.
39. Marinach-Patrice C, Fekkar A, Atanasova R, Gomes J, Djamdjian L, Brossas JY, Meyer I, Buffet P, Snounou G, Datry A, Hennequin C, Golmard JL, Mazier D. 2010. Rapid species diagnosis for invasive candidiasis using mass spectrometry. PLoS One 5(1):e8862. doi:10.1371 /journal.pone.0008862.
40. Spanu T, Posteraro B, Fiori B, D'Inzeo T, Campoli S, Ruggeri A, Tumbarello M, Canu G, Trecarichi EM, Parisi G, Tronci M, Sanguinetti M, Fadda G. 2012. Direct MALDI-TOF mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories. J. Clin. Microbiol. 50:176-179.
41. Buchan BW, Riebe KM, Ledeboer NA. 2012. Comparison of the MALDI Biotyper system using Sepsityper specimen processing to routine microbiological methods for identification of bacteria from positive blood culture bottles. J. Clin. Microbiol. 50:346-352.
42. Ferreira L, Sanchez-Juanes F, Porras-Guerra I, Garcia-Garcia MI, Garcia-Sanchez JE, Gonzalez-Buitrago JM, Munoz-Bellido JL. 2011. Microorganisms direct identification from blood culture by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin. Microbiol. Infect. 17:546-551.
43. Yan Y, He Y, Maier T, Quinn C, Shi G, Li H, Stratton CW, Kostrzewa M, Tang YW. 2011. Improved identification of yeast species directly from positive blood culture media by combining Sepsityper specimen processing and Microflex analysis with the matrix-assisted laser desorption ionization Biotyper system. J. Clin. Microbiol. 49:2528-2532.
44. Lartigue MF, Hery-Arnaud G, Haguenoer E, Domelier AS, Schmit PO, van der Mee-Marquet N, Lanotte P, Mereghetti L, Kostrzewa M, Quentin R. 2009. Identification of Streptococcus agalactiae isolates from various phylogenetic lineages by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 47:2284-2287.
45. Pinto A, Halliday C, Zahra M, van Hal S, Olma T, Maszewska K, Iredell JR, Meyer W, Chen SC. 2011. Matrix-assisted laser desorption ionization-time of flight mass spectrometry identification of yeasts is contingent on robust reference spectra. PLoS One 6(10):e25712. doi:10.1371/journal .pone.0025712.
46. McTaggart LR, Lei E, Richardson SE, Hoang L, Fothergill A, Zhang SX. 2011. Rapid identification of Cryptococcus neoformans and Cryptococcus gattii by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 49:3050-3053.
47. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-third edition. CLSI document m27-A3. Clinical and Laboratory Standards Institute, Wayne, PA.
48. Pfaller MA. 2012. Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am. J. Med. 125(1 Suppl):S3-S13.
49. Marinach C, Alanio A, Palous M, Kwasek S, Fekkar A, Brossas JY, Brun S, Snounou G, Hennequin C, Sanglard D, Datry A, Golmard JL, Mazier D. 2009. MALDI-TOF MS-based drug susceptibility testing of pathogens: the example of Candida albicans and fluconazole. Proteomics 9:4627-4631.
50. De Carolis E, Vella A, Florio AR, Posteraro P, Perlin DS, Sanguinetti M, Posteraro B. 2012. Use of matrix-assisted laser desorption ionizationtime of flight mass spectrometry for caspofungin susceptibility testing of Candida and Aspergillus species. J. Clin. Microbiol. 50:2479-2483.
51. Neville SA, Lecordier A, Ziochos H, Chater MJ, Gosbell IB, Maley MW, van Hal SJ. 2011. Utility of matrix-assisted laser desorption ionizationtime of flight mass spectrometry following introduction for routine laboratory bacterial identification. J. Clin. Microbiol. 49:2980-2984.